These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 3455879)
21. Establishment of a human myeloma cell line with growth-promoting activity for bone marrow-derived fibroblastoid colony-forming cells. Takahira H; Kozuru M; Hirata J; Obama K; Uike N; Iguchi H; Miyamura T; Yamashita S; Kono A; Umemura T Exp Hematol; 1994 Mar; 22(3):261-6. PubMed ID: 8112425 [TBL] [Abstract][Full Text] [Related]
22. Partial purification of a growth factor synthesized by a rat hepatoma cell line established in serum-free medium. Matsuda H; Matsumoto M; Haraguchi S; Kanai K Cancer Res; 1989 Apr; 49(8):2118-22. PubMed ID: 2702652 [TBL] [Abstract][Full Text] [Related]
23. Characterization and partial purification of an endothelial cell growth factor from human platelets. King GL; Buchwald S J Clin Invest; 1984 Feb; 73(2):392-6. PubMed ID: 6365972 [TBL] [Abstract][Full Text] [Related]
24. Stimulation of low density lipoprotein receptor activity by conditioned medium from a human cancer cell line. Shiroeda O; Yamaguchi N; Kawai K Cancer Res; 1987 Sep; 47(17):4630-3. PubMed ID: 3621157 [TBL] [Abstract][Full Text] [Related]
25. [The cultivation features, growth characteristics and oncogenicity of "serum-free" populations of transformed fibroblasts]. Pleskach VA; Kozhukharova IV; Artsybasheva IV; Goĭlo TA; Tarunina MV; Filatova NA Tsitologiia; 1994; 36(8):806-15. PubMed ID: 7701611 [TBL] [Abstract][Full Text] [Related]
26. Evidence for a novel pituitary factor that potentiates the mitogenic effect of estrogen in human breast cancer cells. Dembinski TC; Leung CK; Shiu RP Cancer Res; 1985 Jul; 45(7):3083-9. PubMed ID: 4005846 [TBL] [Abstract][Full Text] [Related]
27. Clonal growth of human acute myeloid leukemia cells (ML-1 and HL-60) in serum-free agar medium. Taketazu F; Kubota K; Kajigaya S; Shionoya S; Motoyoshi K; Saito M; Takaku F; Miura Y Cancer Res; 1984 Feb; 44(2):531-5. PubMed ID: 6607105 [TBL] [Abstract][Full Text] [Related]
28. Production of growth-inhibitory activity in serum-free medium by human monocytic leukemia cells. Gaffney EV; Tsai SC; Dell'Aquila ML; Lingenfelter SE Cancer Res; 1983 Aug; 43(8):3668-73. PubMed ID: 6344988 [TBL] [Abstract][Full Text] [Related]
29. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation. Kawano M; Iwato K; Kuramoto A J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108 [TBL] [Abstract][Full Text] [Related]
30. The growth requirements of BHK-21 cells in serum-free culture. Bradshaw GL; Sato GH; McClure DB; Dubes GR J Cell Physiol; 1983 Feb; 114(2):215-21. PubMed ID: 6218177 [TBL] [Abstract][Full Text] [Related]
31. BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12). Harada N; Kikuchi Y; Tominaga A; Takaki S; Takatsu K J Immunol; 1985 Jun; 134(6):3944-51. PubMed ID: 3872907 [TBL] [Abstract][Full Text] [Related]
32. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha. Ethier SP; Langton BC; Dilts CA Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580 [TBL] [Abstract][Full Text] [Related]
33. Chemical and biological properties of a growth factor from human-cultured osteosarcoma cells: resemblance with platelet-derived growth factor. Heldin CH; Westermark B; Wasteson A J Cell Physiol; 1980 Nov; 105(2):235-46. PubMed ID: 6936400 [TBL] [Abstract][Full Text] [Related]
34. Growth factor production by sarcoma cells in primary culture. Bell RS; Bell DF; Jacob J; Trippel S; Gebhardt MC; Mankin HJ J Orthop Res; 1989; 7(4):468-73. PubMed ID: 2738765 [TBL] [Abstract][Full Text] [Related]
35. Human mesothelioma cells produce factors that stimulate the production of hyaluronan by mesothelial cells and fibroblasts. Asplund T; Versnel MA; Laurent TC; Heldin P Cancer Res; 1993 Jan; 53(2):388-92. PubMed ID: 8417831 [TBL] [Abstract][Full Text] [Related]
36. Rat leukaemia cell line grown on a chemically defined medium. Okano H; Nishiyama T Biomedicine; 1976 Dec; 25(9):321-4. PubMed ID: 1000038 [TBL] [Abstract][Full Text] [Related]
37. Anchorage-dependent growth factor(s) produced by rat sarcoma (XC) cells. Madeja Z; Klein A Folia Histochem Cytobiol; 1992; 30(3):97-101. PubMed ID: 1286729 [TBL] [Abstract][Full Text] [Related]
38. A CD4+ T cell line-secreted factor, growth promoting for normal and leukemic B cells, identified as thioredoxin. Rosen A; Lundman P; Carlsson M; Bhavani K; Srinivasa BR; Kjellström G; Nilsson K; Holmgren A Int Immunol; 1995 Apr; 7(4):625-33. PubMed ID: 7547690 [TBL] [Abstract][Full Text] [Related]
39. N-terminal amino acid sequence of leukemia derived growth factor (LGF) from human erythroleukemia cell culture. Mihara A; Fujiwara K; Sato S; Okabe T; Fujiyoshi N In Vitro Cell Dev Biol; 1987 Apr; 23(4):317-22. PubMed ID: 3032891 [TBL] [Abstract][Full Text] [Related]
40. Long-term cultivation and differentiation of human erythroleukemia cells in a protein-free chemically defined medium. Okabe T; Fujisawa M; Takaku F Proc Natl Acad Sci U S A; 1984 Jan; 81(2):453-5. PubMed ID: 6582502 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]